BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Investigation of over-expressing Annexin receptor cell line with and without agonists

Dataset: Investigation of over-expressing Annexin receptor cell line with and without agonists

The therapeutic potential of pro-resolution factors in determining the outcome of inflammatory events has gained ground over the past...

Registered by ArrayExpress Uploader
View Dataset

The therapeutic potential of pro-resolution factors in determining the outcome of inflammatory events has gained ground over the past decade. However, the attention has been focused on the non-genomic effects of these endogenous, anti-inflammatory substances. In this study, we have focused our attention on identifying specific annexin 1 (AnxA1) protein/ALX receptor mediated gene activation, in an effort to identify down-stream genomic targets of this well-known, glucocorticoid induced, pro-resolution factor. In this study, we used four different types of samples (with 2 replicates each):1)cells transfected with the empty pGEX-4T-327 vector and vehicle (PBS) treated; 2)cells transfected with the annexin receptor ALXR (also known as FPR2) and vehicle (PBS) treated; 3)cells transfected with the annexin receptor ALXR and treated with 10uM Ac-26 peptide for 4 hours; 4) cells transfected with the annexin receptor ALXR and treated with 0.5uM Annexin 1 for 4 hours. After the treatments, cells were collected for RNA extraction.

Species:
human

Samples:
8

Source:
E-GEOD-14807

PubMed:
20862244

Updated:
Dec.12, 2014

Registered:
Sep.11, 2014


Factors: (via ArrayExpress)
Sample
GSM370545 1
GSM370550 1
GSM370551 1
GSM370552 1
GSM370553 1
GSM370554 1
GSM370555 1
GSM370556 1

Tags

  • protein

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use